Ad is loading...
A
Price
$127.07
Change
-$3.15 (-2.42%)
Updated
Nov 15 closing price
7 days until earnings call
HSDT
Price
$0.51
Change
-$0.04 (-7.27%)
Updated
Nov 15 closing price
Ad is loading...

A vs HSDT

Header iconA vs HSDT Comparison
Open Charts A vs HSDTBanner chart's image
Agilent Technologies
Price$127.07
Change-$3.15 (-2.42%)
Volume$2.63M
CapitalizationN/A
Helius Medical Technologies
Price$0.51
Change-$0.04 (-7.27%)
Volume$104.04K
CapitalizationN/A
A vs HSDT Comparison Chart
Loading...
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
HSDT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
A vs. HSDT commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a StrongSell and HSDT is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (A: $127.07 vs. HSDT: $0.51)
Brand notoriety: A and HSDT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 165% vs. HSDT: 27%
Market capitalization -- A: $42.66B vs. HSDT: $5.17M
A [@Medical Specialties] is valued at $42.66B. HSDT’s [@Medical Specialties] market capitalization is $5.17M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 1 FA rating(s) are green whileHSDT’s FA Score has 1 green FA rating(s).

  • A’s FA Score: 1 green, 4 red.
  • HSDT’s FA Score: 1 green, 4 red.
According to our system of comparison, A is a better buy in the long-term than HSDT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 4 TA indicator(s) are bullish while HSDT’s TA Score has 6 bullish TA indicator(s).

  • A’s TA Score: 4 bullish, 6 bearish.
  • HSDT’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, HSDT is a better buy in the short-term than A.

Price Growth

A (@Medical Specialties) experienced а -7.03% price change this week, while HSDT (@Medical Specialties) price change was -9.35% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Reported Earning Dates

A is expected to report earnings on Feb 25, 2025.

HSDT is expected to report earnings on Nov 15, 2023.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($42.7B) has a higher market cap than HSDT($5.17M). A has higher P/E ratio than HSDT: A (34.82) vs HSDT (0.14). A YTD gains are higher at: -8.138 vs. HSDT (-93.595). A has higher annual earnings (EBITDA): 1.69B vs. HSDT (-10.99M). HSDT has less debt than A: HSDT (70K) vs A (2.56B). A has higher revenues than HSDT: A (6.74B) vs HSDT (792K).
AHSDTA / HSDT
Capitalization42.7B5.17M825,919%
EBITDA1.69B-10.99M-15,378%
Gain YTD-8.138-93.5959%
P/E Ratio34.820.1424,052%
Revenue6.74B792K850,379%
Total CashN/A6.6M-
Total Debt2.56B70K3,650,000%
FUNDAMENTALS RATINGS
A vs HSDT: Fundamental Ratings
A
HSDT
OUTLOOK RATING
1..100
5736
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
26
Undervalued
PROFIT vs RISK RATING
1..100
44100
SMR RATING
1..100
4098
PRICE GROWTH RATING
1..100
6191
P/E GROWTH RATING
1..100
78100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (20) in the Biotechnology industry is in the same range as HSDT (26) in the Medical Specialties industry. This means that A’s stock grew similarly to HSDT’s over the last 12 months.

A's Profit vs Risk Rating (44) in the Biotechnology industry is somewhat better than the same rating for HSDT (100) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than HSDT’s over the last 12 months.

A's SMR Rating (40) in the Biotechnology industry is somewhat better than the same rating for HSDT (98) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than HSDT’s over the last 12 months.

A's Price Growth Rating (61) in the Biotechnology industry is in the same range as HSDT (91) in the Medical Specialties industry. This means that A’s stock grew similarly to HSDT’s over the last 12 months.

A's P/E Growth Rating (78) in the Biotechnology industry is in the same range as HSDT (100) in the Medical Specialties industry. This means that A’s stock grew similarly to HSDT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AHSDT
RSI
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
60%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
55%
Bullish Trend 3 days ago
72%
MACD
ODDS (%)
Bearish Trend 3 days ago
62%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
57%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 13 days ago
63%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
57%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 4 days ago
85%
Aroon
ODDS (%)
Bearish Trend 3 days ago
67%
Bullish Trend 3 days ago
68%
View a ticker or compare two or three
Ad is loading...
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
HSDT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BJ87.270.30
+0.34%
BJs Wholesale Club Holdings
PHX3.710.01
+0.27%
PHX Minerals
MWA24.31-0.11
-0.45%
Mueller Water Products
NR6.99-0.13
-1.83%
Newpark Resources
VVPR0.82-0.53
-39.13%
VivoPower International PLC

HSDT and

Correlation & Price change

A.I.dvisor indicates that over the last year, HSDT has been loosely correlated with STSS. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if HSDT jumps, then STSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSDT
1D Price
Change %
HSDT100%
-5.87%
STSS - HSDT
36%
Loosely correlated
-5.69%
HSCS - HSDT
32%
Poorly correlated
-1.52%
A - HSDT
24%
Poorly correlated
-2.42%
STE - HSDT
24%
Poorly correlated
-0.48%
SHC - HSDT
23%
Poorly correlated
-4.54%
More